Module MSE-4082:
Ethical Legal & Social Consid
Ethical, Legal and Social Considerations in Genomics 2023-24
MSE-4082
2023-24
North Wales Medical School
Module - Semester 1 & 2
15 credits
Module Organiser:
Lynne Williams
Overview
- ELSI issues for genomic medicine – confidentiality, autonomy, disclosure, informed consent, natural justice_x000D_
- Effects of opportunistic predictive, incidental or uncertain-significance results_x000D_
- Impact of genomic testing on individuals, and demographic and ethnic difference_x000D_
- Social implications of genetic testing and screening.x000D
- Legal aspects of genomic information in relation to diagnostic, therapeutic, and research use and patenting of genomic information and tests_x000D_
- Obtaining ethical approval for research projects_x000D_
- Specific ELSI issues as applied to clinical pathways.x000D
Learning Outcomes
- Critically appraise the current legal framework within which genomic medicine is practised in the UK, Europe, USA and globally_x000D_
- Critically appraise the global impact of genetic databases on human autonomy, healthcare provision and discrimination
- Critically evaluate and defend the principles of the Helsinki Declaration under which all medical research is performed with specific reference to genetic research
- Critically evaluate the challenges of emerging genomic technologies on society and societal values
- Explain and defend the ethical principles of confidentiality, autonomy, disclosure, informed consent and natural justice to scenarios within genomic medicine in a global context
- Identify and critically evaluate the ethical, legal and social impact of genomic medical advances in a clinical pathway
- Identify those clinical pathways in their own specialty or field of practice where the use of genomic investigation/techniques may be beneficial to patients, and be able to argue for those benefits.
Assessment method
Coursework
Assessment type
Crynodol
Description
Essay or coursework
Weighting
65%
Assessment method
Coursework
Assessment type
Crynodol
Description
Report
Weighting
35%